ArticleJournal of endocrinological investigation2025
A Prospective Study to Determine Trimester-Specific Thyroid Function Reference Intervals.
Article in Journal of endocrinological investigation, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evolving Concepts in Gestational Iodine Requirements.Healthcare (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposePrecise thyroid function assessment during pregnancy prevents inaccurate diagnosis of thyroid disease. This study aimed to establish trimester-specific reference intervals for thyroid function tests (TFTs) in Taiwanese pregnant women and analyze thyroid hormone and anti-thyroid antibody changes through gestation.
methodsThis prospective study at Taipei Veterans General Hospital (2019-2022) included 209 pregnant women. After excluding those with positive anti-thyroid antibodies, use of thyroid-related medications, or plans for abortion, 123 participants were eligible for thyroid function reference interval analysis. TFTs including thyroid-stimulating hormone (TSH), free T4, total T4, free T3, and total T3 along with antibodies were measured once per trimester using a Roche electrochemiluminescence immunoassay. One spot urine sample from each woman was collected at baseline to ensure iodine adequacy and urinary iodine concentration was measured by inductively coupled mass spectrometry.
resultsThe median urinary iodine concentration was 162.5 µg/L, indicating that the analyzed population had sufficient iodine status. TSH levels were significantly lower in the first trimester (0.007-3.08 µIU/mL) compared to the second (0.33-4.55 µIU/mL) and third trimesters (0.29-4.64 µIU/mL) (p < 0.001). Levels of free T4 and free T3 decreased consistently throughout pregnancy (p < 0.001), while total T3 levels remained stable. In contrast, total T4 levels, anti-thyroid peroxidase antibody titers, and the proportion of women with positive anti-thyrotropin receptor antibodies were higher in the first trimester compared to the second and third trimesters.
conclusionsThis study underscores the importance of trimester-specific, population-based reference intervals for TFTs using the Roche assay and represents the first investigation in Taiwanese populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.